| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -221,643 | -155,830 |
| Net change in cash and cash equivalents | -174,817 | -167,028 |
| Cash and cash equivalents at beginning of period | 448,346 | - |
| Cash and cash equivalents at end of period | 273,529 | - |
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)